胃癌围手术期治疗新进展20150527.pptVIP

* * * For perioperative treatment, adjuvant chemotherapy and neoadjuvant chemotherapy have already got widely accepted by most of Chinese physicians, and been applied in clinical practice. * Compared with other countries, China has the similar therapeutic efficacy in patients of early gastric cancer and part of advanced gastric cancer patients . But, in patients with latter stages, the therapeutic efficacy is not as good as other countries. * 可切除的胃和低位食道癌的围手术期化疗: 明显提高无进展生存时间 明显延长总体生存期 缩小了肿瘤体积并明显延长了DFS和OS。1 MAIGC研究（随机分组临床III期研究比较单纯手术和术前术后使用表柔比星+顺铂+5－氟尿嘧啶化疗+手术患者的预后）的结果显示相比单纯手术，手术联合术前术后化疗带来生存获益。1